VALGIUSTI, MARTINA
VALGIUSTI, MARTINA
DIPARTIMENTO DI MEDICINA SPECIALISTICA, DIAGNOSTICA E SPERIMENTALE (attivo dal 28/10/2011 al 31/12/2022)
Analysis of EVs from patients with advanced pancreatic cancer identifies antigens and miRNAs with predictive value
2023 Vannini I.; Rossi T.; Melloni M.; Valgiusti M.; Urbini M.; Passardi A.; Bartolini G.; Gallio C.; Azzali I.; Bandini S.; Ancarani V.; Montanaro L.; Frassineti G.L.; Fabbri F.; Rapposelli I.G.
ANGPT2 and NOS3 polymorphisms and clinical outcome in advanced hepatocellular carcinoma patients receiving sorafenib
2019 Giorgia Marisi, Elisabetta Petracci, Francesco Raimondi, Luca Faloppi, Francesco Giuseppe Foschi, Gianfranco Lauletta, Massimo Iavarone, Matteo Canale, Martina Valgiusti, Luca Maria Neri, Paola Ulivi, Giulia Orsi, Giulia Rovesti, Ranka Vukotic, Fabio Conti, Alessandro Cucchetti, Giorgio Ercolani, Kalliopi Andrikou, Stefano Cascinu, Mario Scartozzi, Andrea Casadei-Gardini
Chemoradiotherapy (Gemox plus helical tomotherapy) for unresectable locally advanced pancreatic cancer: A phase II study
2019 Alessandro Passardi, Emanuela Scarpi, Elisa Neri, Elisabetta Parisi, Giulia Ghigi, Giorgio Ercolani, Andrea Gardini, Giuliano La Barba, Flavia Pagan, Andrea Casadei-Gardini, Martina Valgiusti, Fabio Ferroni, Giovanni Luca Frassineti, Antonino Romeo
Cna profiling of single ctcs in locally advanced esophageal cancer patients during therapy highlights unexplored molecular pathways
2021 Gallerani G.; Rossi T.; Valgiusti M.; Angeli D.; Fici P.; De Fanti S.; Bandini E.; Cocchi C.; Frassineti G.L.; Bonafe' M.; Fabbri F.
Conversion Surgery in Gastric Cancer Carcinomatosis
2022 Morgagni P.; Solaini L.; Saragoni L.; Monti M.; Valgiusti M.; Vittimberga G.; Frassineti G.L.; Framarini M.; Ercolani G.
Endoscopic ultrasound-guided jejuno-jejunal anastomosis for malignant outlet obstruction after total gastrectomy
2021 Lisotti, Andrea; Calvanese, Claudio; Valgiusti, Martina; Bacchilega, Igor; Fusaroli, Pietro
Multimodal treatment with gemox plus helical tomotherapy in unresectable locally advanced pancreatic cancer: A pooled analysis of two phase 2 studies
2021 Passardi A.; Rapposelli I.G.; Scarpi E.; Sullo F.G.; Bartolini G.; Neri E.; Ghigi G.; Tontini L.; Ercolani G.; Monti M.; Ruscelli S.; Matteucci L.; Valgiusti M.; Frassineti G.L.; Romeo A.
Neoadjuvant treatment (FOLFOX4 plus hypofractionated tomotherapy) for patients with locally advanced rectal cancer: a multicenter phase II trial
2020 Passardi A.; Rapposelli I.G.; Scarpi E.; Neri E.; Parisi E.; Ghigi G.; Ercolani G.; Avanzolini A.; Cavaliere D.; Rudnas B.; Valgiusti M.; Barone D.; Ferroni F.; Frassineti G.L.; Romeo A.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Analysis of EVs from patients with advanced pancreatic cancer identifies antigens and miRNAs with predictive value | Vannini I.; Rossi T.; Melloni M.; Valgiusti M.; Urbini M.; Passardi A.; Bartolini G.; Gallio C.; ...Azzali I.; Bandini S.; Ancarani V.; Montanaro L.; Frassineti G.L.; Fabbri F.; Rapposelli I.G. | 2023-01-01 | MOLECULAR THERAPY. METHODS & CLINICAL DEVELOPMENT | - | 1.01 Articolo in rivista | - |
| ANGPT2 and NOS3 polymorphisms and clinical outcome in advanced hepatocellular carcinoma patients receiving sorafenib | Giorgia Marisi, Elisabetta Petracci, Francesco Raimondi, Luca Faloppi, Francesco Giuseppe Foschi,... Gianfranco Lauletta, Massimo Iavarone, Matteo Canale, Martina Valgiusti, Luca Maria Neri, Paola Ulivi, Giulia Orsi, Giulia Rovesti, Ranka Vukotic, Fabio Conti, Alessandro Cucchetti, Giorgio Ercolani, Kalliopi Andrikou, Stefano Cascinu, Mario Scartozzi, Andrea Casadei-Gardini | 2019-01-01 | CANCERS | - | 1.01 Articolo in rivista | 2019-Marisi (Cancers)-ANGPT e NOS3 polimorfismo in HCC.pdf; cancers-11-01023-s001.pdf |
| Chemoradiotherapy (Gemox plus helical tomotherapy) for unresectable locally advanced pancreatic cancer: A phase II study | Alessandro Passardi, Emanuela Scarpi, Elisa Neri, Elisabetta Parisi, Giulia Ghigi, Giorgio Ercola...ni, Andrea Gardini, Giuliano La Barba, Flavia Pagan, Andrea Casadei-Gardini, Martina Valgiusti, Fabio Ferroni, Giovanni Luca Frassineti, Antonino Romeo | 2019-01-01 | CANCERS | - | 1.01 Articolo in rivista | 2019-Passardi (Cancers)-chemoradiotherapy x unresectable K pancreas.pdf |
| Cna profiling of single ctcs in locally advanced esophageal cancer patients during therapy highlights unexplored molecular pathways | Gallerani G.; Rossi T.; Valgiusti M.; Angeli D.; Fici P.; De Fanti S.; Bandini E.; Cocchi C.; Fra...ssineti G.L.; Bonafe' M.; Fabbri F. | 2021-01-01 | CANCERS | - | 1.01 Articolo in rivista | 34944989_Bonafe.pdf; cancers-13-06369-s001.zip |
| Conversion Surgery in Gastric Cancer Carcinomatosis | Morgagni P.; Solaini L.; Saragoni L.; Monti M.; Valgiusti M.; Vittimberga G.; Frassineti G.L.; Fr...amarini M.; Ercolani G. | 2022-01-01 | FRONTIERS IN ONCOLOGY | - | 1.01 Articolo in rivista | fonc-12-852559.pdf |
| Endoscopic ultrasound-guided jejuno-jejunal anastomosis for malignant outlet obstruction after total gastrectomy | Lisotti, Andrea; Calvanese, Claudio; Valgiusti, Martina; Bacchilega, Igor; Fusaroli, Pietro | 2021-01-01 | ENDOSCOPY | - | 1.01 Articolo in rivista | - |
| Multimodal treatment with gemox plus helical tomotherapy in unresectable locally advanced pancreatic cancer: A pooled analysis of two phase 2 studies | Passardi A.; Rapposelli I.G.; Scarpi E.; Sullo F.G.; Bartolini G.; Neri E.; Ghigi G.; Tontini L.;... Ercolani G.; Monti M.; Ruscelli S.; Matteucci L.; Valgiusti M.; Frassineti G.L.; Romeo A. | 2021-01-01 | BIOMOLECULES | - | 1.01 Articolo in rivista | 2021-Passardi (Biomolecules) multimodal treatment x unresectable pancreatic cancer.pdf; biomolecules-11-01200-s001.zip |
| Neoadjuvant treatment (FOLFOX4 plus hypofractionated tomotherapy) for patients with locally advanced rectal cancer: a multicenter phase II trial | Passardi A.; Rapposelli I.G.; Scarpi E.; Neri E.; Parisi E.; Ghigi G.; Ercolani G.; Avanzolini A....; Cavaliere D.; Rudnas B.; Valgiusti M.; Barone D.; Ferroni F.; Frassineti G.L.; Romeo A. | 2020-01-01 | THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY | - | 1.01 Articolo in rivista | 1758835920977139.pdf |